Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Dr Reddys Labs Ltd Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for DR REDDYS LABS LTD, and what generic and branded alternatives to DR REDDYS LABS LTD drugs are available?

DR REDDYS LABS LTD has one hundred and twenty-nine approved drugs.

There are eighteen tentative approvals on DR REDDYS LABS LTD drugs.

Summary for Dr Reddys Labs Ltd

US Patents:	0
Tradenames:	101
Ingredients:	96
NDAs:	129

Drugs and US Patents for Dr Reddys Labs Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys Labs Ltd	OLANZAPINE	olanzapine	TABLET, ORALLY DISINTEGRATING;ORAL	076534-003	Oct 24, 2011	AB	RX	No	No		⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
Dr Reddys Labs Ltd	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201576-002	Jun 6, 2012	AB	RX	No	No		⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
Dr Reddys Labs Ltd	RISPERIDONE	risperidone	TABLET, ORALLY DISINTEGRATING;ORAL	077328-004	Nov 30, 2009	AB	RX	No	No		⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
Dr Reddys Labs Ltd	ATOMOXETINE HYDROCHLORIDE	atomoxetine hydrochloride	CAPSULE;ORAL	090609-001	Feb 23, 2018	AB	RX	No	No		⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for DR REDDYS LABS LTD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Medtronic

McKesson

Dow

McKinsey

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.